| Description |
1 online resource (xxi, 215 pages) : illustrations |
| Series |
Directions in development |
|
Directions in development (Washington, D.C.)
|
| Contents |
Pharmaceutical policy goals -- Introducing the stakeholders -- Patterns of dysfunction -- Key elements of a successful pharmaceutical policy -- Policy packages to achieve strategic long-term goals -- Factors influencing policy implementation -- Pharmaceutical policy illustrated in country examples -- Pharmaceutical policy outlook |
| Summary |
Pharmaceuticals are an essential component of health care. But for many people in low- and middle-income countries, access to the medicines they need to prevent or treat severe illnesses is limited. Typical problems are lack of availability, costs that exceed the individual's purchasing power or lack of competent "agents"--Health workers that are well trained to give the correct advice on which medicines to take. Pharmaceutical policy is the part of health policy that aims at addressing these problems and increasing access to safe, effective and affordable medicines for all patients. There are many obstacles against achieving these goals. Such obstacles can arise from financial interests on the side of suppliers and health care providers, who may benefit from charging higher prices and issuing more prescriptions than might be justified from a clinical and economic viewpoint. Or from rogue suppliers trying to introduce low quality or counterfeit drugs into markets with less effective regulation. Also, corruption and ineffective bureaucracies sometimes interfere with well intended programs to offer access to essential medicines for the poor. This book offers policy makers a hands-on approach, tested in the World Bank's field work in many countries, for assessing the pharmaceutical sector, recognizing typical "patterns of dysfunction" and developing strategies to quickly deal with the most urgent problems while at the same time building a platform for sustainable long term policy. It offers examples from a variety of low- and middle income countries and provides practical assessment tools for policy makers. The book ends with the author's outlook on future developments in this complex policy field |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212 MiAaHDL |
|
English |
|
digitized 2011 HathiTrust Digital Library committed to preserve pda MiAaHDL |
| Subject |
Pharmaceutical policy.
|
|
Drug Industry -- organization & administration
|
|
Developed Countries
|
|
Government Regulation
|
|
Health Plan Implementation
|
|
Health Policy -- economics
|
|
MEDICAL -- Allied Health Services -- General.
|
|
Pharmaceutical policy
|
| Form |
Electronic book
|
| Author |
World Bank.
|
| LC no. |
2010015420 |
| ISBN |
9780821383865 |
|
0821383868 |
|
9780821383872 |
|
0821383876 |
|
1282725645 |
|
9781282725645 |
|
6612725648 |
|
9786612725647 |
|
